Astrazeneca PLC (NYSE:AZN) Posts Basic Consolidated EPS Of $2.2358

0

Astrazeneca PLC (NYSE:AZN)managed to report annual basic consolidated EPS of $2.2358, which was for the year ended2015-12-31.The company reported basic consolidated EPS of $2.2358 for the quarter ended 2015-12-31.

EPS from continuing operations

If you look at the performance of the company’s continuing operations, you see that EPS generated from such operations was {EPS_BASIC_CONT_OPER:1541}} for the year ended 2015-12-31. As for the quarter ended 2015-12-31, continuing operations produced EPS of $-0.0245.

EPS contribution from parent

Astrazeneca PLC (NYSE:AZN) received of $2.235 EPS boost from the parent company for the annual period ended

For the year ended 2015-12-31, the parent of Astrazeneca PLC (NYSE:AZN) contributed EPS of $2.235 to the company’s bottom-line. But for the quarter ended 2015-12-31, EPS boost from the parent was cited as $2.235.

What About Basic net EPS

The basic net EPS that Astrazeneca PLC (NYSE:AZN) reported for the year ended 2015-12-31 stood at $2.23. For the quarter ended 2015-12-31, the company posted basic net EPS of $2.23.

What About Consolidated Diluted EPS?

Astrazeneca PLC (NYSE:AZN)’s consolidated diluted EPS for the year ended 2015-12-31 was reported as $2.234. For the quarter ended 2015-12-31 the metric was$2.234.

Basic diluted EPS

The company managed to register diluted EPS from continuing operation of at $2.234 for the yearended 2015-12-31. But diluted EPS from continuing operations for the quarter ended 2015-12-31 came in at $2.234.

Net diluted EPS

Net diluted EPS posted by Astrazeneca PLC (NYSE:AZN) for the year ended 2015-12-31 was $2.23. On quarterly basis, net diluted EPS for the quarter ended 2015-12-31 was reported as $2.23.

What portion of diluted EPS came from parent?

For the annual period ended 2015-12-31, the parent company of Astrazeneca PLC (NYSE:AZN) said that it parent company boosted its diluted EPS by$2.2332 in the year ended 2015-12-31. For the quarter ended 2015-12-31, the parent company’s contribution to diluted EPS was $2.2332.

The company reported net basic EPS of $2.23 for the year ended 2015-12-31 and net basic EPS of $2.23 for the quarter ended 2015-12-31.

The number of Astrazeneca PLC (NYSE:AZN)’s basic shares outstanding at the end of the annual period ended 2015-12-31 was 1264. That compares with 1264 basic shares outstanding for the quarter ended 2015-12-31.

Astrazeneca PLC (NYSE:AZN) had 1264 diluted shares outstanding at the end of the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, diluted outstanding shares were 1264.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 16 times, 1 visits today)